Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.

CEO

Lars Fruergaard Jørgensen

CEOLars Fruergaard Jørgensen

Employees

76,302

Employees76,302

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1931

Founded1931

Employees

76,302

Employees76,302

NVO Key Statistics

Market cap

290.70B

Market cap290.70B

Price-Earnings ratio

19.68

Price-Earnings ratio19.68

Dividend yield

1.83%

Dividend yield1.83%

Average volume

9.86M

Average volume9.86M

High today

$66.20

High today$66.20

Low today

$66.20

Low today$66.20

Open price

$66.41

Open price$66.41

Volume

22.72K

Volume22.72K

52 Week high

$148.15

52 Week high$148.15

52 Week low

$59.32

52 Week low$59.32

NVO News

Benzinga 7d

Trump Administration Reverses Biden's Plan For Medicare Coverage Of Obesity Drugs Like Ozempic And Zepbound

On Monday, the U.S. Centers for Medicare & Medicaid Services (CMS) released its 2026 payment update for Medicare Advantage (MA) and Medicare Part D prescription...

Analyst ratings

70%

of 33 ratings

Buy

69.7%

Hold

24.2%

Sell

6.1%